SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.
Expert Ratings for Amylyx Pharma
Amylyx Pharma (NASDAQ:AMLX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…